135 related articles for article (PubMed ID: 25862198)
1. Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity.
Desai AJ; Henke BR; Miller LJ
Bioorg Med Chem Lett; 2015 May; 25(9):1849-55. PubMed ID: 25862198
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Action of a Small-Molecule Positive Allosteric Modulator Agonist at the Type 1 Cholecystokinin Holoreceptor.
Desai AJ; Mechin I; Nagarajan K; Valant C; Wootten D; Lam PCH; Orry A; Abagyan R; Nair A; Sexton PM; Christopoulos A; Miller LJ
Mol Pharmacol; 2019 Mar; 95(3):245-259. PubMed ID: 30591538
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol.
Harikumar KG; Coudrat T; Desai AJ; Dong M; Dengler DG; Furness SGB; Christopoulos A; Wootten D; Sergienko EA; Sexton PM; Miller LJ
Front Endocrinol (Lausanne); 2021; 12():789957. PubMed ID: 34950108
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
Miller LJ; Desai AJ
Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.
Desai AJ; Lam PC; Orry A; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
J Med Chem; 2015 Dec; 58(24):9562-77. PubMed ID: 26654202
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor.
Harikumar KG; Cawston EE; Lam PCH; Patil A; Orry A; Henke BR; Abagyan R; Christopoulos A; Sexton PM; Miller LJ
J Biol Chem; 2013 Jul; 288(29):21082-21095. PubMed ID: 23754289
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor.
Gao F; Sexton PM; Christopoulos A; Miller LJ
Bioorg Med Chem Lett; 2008 Aug; 18(15):4401-4. PubMed ID: 18621527
[TBL] [Abstract][Full Text] [Related]
8. Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity.
Dengler DG; Sun Q; Harikumar KG; Miller LJ; Sergienko EA
SLAS Discov; 2022 Oct; 27(7):384-394. PubMed ID: 35850480
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger".
Aquino CJ; Armour DR; Berman JM; Birkemo LS; Carr RA; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Head JE; Hirst GC; James MK; Johnson MF; Miller LJ; Queen KL; Rimele TJ; Smith DN; Sugg EE
J Med Chem; 1996 Jan; 39(2):562-9. PubMed ID: 8558528
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituent.
Hirst GC; Aquino C; Birkemo L; Croom DK; Dezube M; Dougherty RW; Ervin GN; Grizzle MK; Henke B; James MK; Johnson MF; Momtahen T; Queen KL; Sherrill RG; Szewczyk J; Willson TM; Sugg EE
J Med Chem; 1996 Dec; 39(26):5236-45. PubMed ID: 8978852
[TBL] [Abstract][Full Text] [Related]
11. A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.
Desai AJ; Harikumar KG; Miller LJ
J Biol Chem; 2014 Jun; 289(26):18314-26. PubMed ID: 24825903
[TBL] [Abstract][Full Text] [Related]
12. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
Henke BR; Aquino CJ; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; Hirst GC; James MK; Johnson MF; Queen KL; Sherrill RG; Sugg EE; Suh EM; Szewczyk JW; Unwalla RJ; Yingling J; Willson TM
J Med Chem; 1997 Aug; 40(17):2706-25. PubMed ID: 9276016
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M
Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056
[TBL] [Abstract][Full Text] [Related]
14. Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.
Hadac EM; Dawson ES; Darrow JW; Sugg EE; Lybrand TP; Miller LJ
J Med Chem; 2006 Feb; 49(3):850-63. PubMed ID: 16451051
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Action and Structure-Activity Relationships of Tetracyclic Small Molecules Acting as Universal Positive Allosteric Modulators of the Cholecystokinin Receptor.
Dengler DG; Harikumar KG; Yen A; Sergienko EA; Miller LJ
Membranes (Basel); 2023 Jan; 13(2):. PubMed ID: 36837653
[TBL] [Abstract][Full Text] [Related]
16. Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics.
Miller LJ; Harikumar KG; Wootten D; Sexton PM
Front Endocrinol (Lausanne); 2021; 12():684656. PubMed ID: 34149622
[TBL] [Abstract][Full Text] [Related]
17. 2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
Berger R; Zhu C; Hansen AR; Harper B; Chen Z; Holt TG; Hubert J; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; Wolff M; Macneil DJ; Weber AE; Edmondson SD
Bioorg Med Chem Lett; 2008 Sep; 18(17):4833-7. PubMed ID: 18684621
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE
Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor.
Wood M; Ates A; Andre VM; Michel A; Barnaby R; Gillard M
Mol Pharmacol; 2016 Feb; 89(2):303-12. PubMed ID: 26655303
[TBL] [Abstract][Full Text] [Related]
20. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
